<html>
<head>PUBMED IDs for prostein</head>
<body bgcolor='#C5F0F2'><h1>prostein</h1><a href='https://pubmed.ncbi.nlm.nih.gov/11245466/'>Identification and characterization of prostein, a novel prostate-specific protein.</a> March 14  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/17667550/'>Immunohistochemical differentiation of high-grade prostate carcinoma from urothelial carcinoma.</a> August 2  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/18193184/'>Ectopic expression of miR-126*, an intronic product of the vascular endothelial EGF-like 7 gene, regulates prostein translation and invasiveness of prostate cancer LNCaP cells.</a> January 15  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18679647/'>[Molecular genetic markers for prostate cancer. Evidence in fine needle biopsies for improved confirmation of the diagnosis].</a> August 6  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/22441574/'>Differentiating rectal carcinoma by an immunohistological analysis of carcinomas of pelvic organs based on the NCBI Literature Survey and the Human Protein Atlas database.</a> September 13  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22821757/'>Loss of SLC45A3 protein (prostein) expression in prostate cancer is associated with SLC45A3-ERG gene rearrangement and an unfavorable clinical course.</a> February 21  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/24925052/'>Comparison of different prostatic markers in lymph node and distant metastases of prostate cancer.</a> March 30  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25216229/'>Prostate adenocarcinomas aberrantly expressing p63 are molecularly distinct from usual-type prostatic adenocarcinomas.</a> November 18  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/26778368/'>Immunohistochemistry of ductal adenocarcinoma of the prostate and adenocarcinomas of non-prostatic origin: a comparative study.</a> July 28  2016<br></body></html>
